Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Javier San Martin
Age : 55
Public asset : 1,479,960 USD
Country of residence : Unknown
Linked companies : Arrowhead Pharmaceuticals, Inc.

Biography of Javier San Martin 
Presently, Javier San Martin is Chief Medical Officer at Arrowhead Pharmaceuticals, Inc. He previously held the position of Executive Director-Bone Therapeutic Area at Amgen, Inc., Principal at Eli Lilly & Co., Senior VP-Global Clinical Development at Ultragenyx Pharmaceutical, Inc. and Senior Vice President-Clinical Development at Alder Biopharmaceuticals, Inc. He received a doctorate from Universidad de Buenos Aires.


Current positions of Javier San Martin 
Holdings of Javier San Martin 
Javier San Martin : Personal Network 
Most Read News 
05/20XAVIER NIEL : UWR shares spike as billionaire Xavier Niel discloses 27% stake
RE
05/12MASAYOSHI SON : SoftBank Vision Fund posts $26 billion loss; Son pledges defence
RE
05/14ELON MUSK : Elon Musk says Twitter legal team told him he violated an NDA
RE
05/24ELON MUSK : In a faceoff with Elon Musk, the SEC blinked
RE
05/19ELON MUSK : Musk says 'Tesla is on my mind 24/7' amid concerns about Twitter distraction
RE
05/17ELON MUSK : Prominent hedge funds invested in Twitter before Musk unveiled plans
RE
05/25ELON MUSK : Twitter investors vote against re-electing Elon Musk ally to board
RE
05/23HOCK TAN : Chipmaker Broadcom in talks to acquire VMware for $60 billion -sources
RE
05/17JPMorgan shareholders vote disapproval of CEO Dimon's special payout
RE
05/12ELON MUSK : Twitter CEO says two leaders to depart, hiring paused amid Musk takeover
RE
More news


© 2022 People and Ownership :   
Javier San Martin : Connections 


Latest news about Javier San Martin 
05/10TRANSCRIPT : Arrowhead Pharmaceuticals, Inc., Q2 2022 Earnings Call, May 10, 2022
CI
02/02TRANSCRIPT : Arrowhead Pharmaceuticals, Inc., Q1 2022 Earnings Call, Feb 02, 2022
CI
2021INSIDER SELL : Arrowhead Pharmaceuticals
MT
2021TRANSCRIPT : Arrowhead Pharmaceuticals, Inc., 2021 Earnings Call, Nov 22, 2021
CI
2021TRANSCRIPT : Arrowhead Pharmaceuticals, Inc. - Special Call
CI
2021TRANSCRIPT : Arrowhead Pharmaceuticals, Inc., Q3 2021 Earnings Call, Aug 05, 2021
CI
2021TRANSCRIPT : Arrowhead Pharmaceuticals, Inc., Q2 2021 Earnings Call, May 04, 2021
CI
More news